(Q34545547)

2 August 2017

1 reference

title

Involvement of oxidative stress in Alzheimer disease (English)

1 reference

2 August 2017

0 references

0 references

5

1 reference

2 August 2017

Paula I Moreira

4

0 references

Xiongwei Zhu

series ordinal

3

object named as

Xiongwei Zhu

1 reference

2 August 2017

6

Mark A Smith

1 reference

2 August 2017

Akihiko Nunomura

1

1 reference

2 August 2017

Rudy J Castellani

series ordinal

2

1 reference

2 August 2017

publication date

1 July 2006

1 reference

Journal of Neuropathology & Experimental Neurology

2 August 2017

published in

1 reference

2 August 2017

volume

65

1 reference

2 August 2017

issue

7

1 reference

2 August 2017

page(s)

631-641

1 reference

Oxidative stress in Alzheimer's disease

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Cell-cycle reentry and cell death in transgenic mice expressing nonmutant human tau isoforms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Iron accumulation in Alzheimer disease is a source of redox-generated free radicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Copper, iron and zinc in Alzheimer's disease senile plaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Metal binding and oxidation of amyloid-beta within isolated senile plaque cores: Raman microscopic evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Neurons may live for decades with neurofibrillary tangles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Prevalence of AD among whites: a summary by levels of severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Oxidative stress, glutamate, and neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Oxidative stress in brain aging. Implications for therapeutics of neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Elevated vulnerability to oxidative stress-induced cell death and activation of caspase-3 by the Swedish amyloid precursor protein mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Neurotoxic mechanisms caused by the Alzheimer's disease-linked Swedish amyloid precursor protein mutation: oxidative stress, caspases, and the JNK pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Increased vulnerability of hippocampal neurons from presenilin-1 mutant knock-in mice to amyloid beta-peptide toxicity: central roles of superoxide production and caspase activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Reduced antioxidant enzyme activity in brains of mice transgenic for human presenilin-1 with single or multiple mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Amyloid precursor proteins inhibit heme oxygenase activity and augment neurotoxicity in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Fibrillar beta-amyloid evokes oxidative damage in a transgenic mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Oxidative stress in synaptosomal proteins from mutant presenilin-1 knock-in mice: implications for familial Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Aging sensitizes toward ROS formation and lipid peroxidation in PS1M146L transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Oxidative stress and reduced antioxidant defenses in peripheral cells from familial Alzheimer's patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Neuronal RNA oxidation is a prominent feature of familial Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

The Swedish APP670/671 Alzheimer's disease mutation: the first evidence for strikingly increased oxidative injury in the temporal inferior cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Apolipoprotein E allele-dependent antioxidant activity in brains with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Distribution of reducible 4-hydroxynonenal adduct immunoreactivity in Alzheimer disease is associated with APOE genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Oxidative damage and protection by antioxidants in the frontal cortex of Alzheimer's disease is related to the apolipoprotein E genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Risk of dementia among persons with diabetes mellitus: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Head injury and the risk of AD in the MIRAGE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Plasma homocysteine as a risk factor for dementia and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Stroke and the risk of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Relation between aluminum concentrations in drinking water and Alzheimer's disease: an 8-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Caloric intake and the risk of Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Patients with Alzheimer's disease have reduced activities in midlife compared with healthy control-group members

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Aluminium in Alzheimer's disease: are we still at a crossroad?

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Pathophysiology of cerebral ischemia and brain trauma: similarities and differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Homocysteine and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Dietary intake of antioxidants and risk of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Amount and type of alcohol and risk of dementia: the Copenhagen City Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Enhanced free radical scavenging and decreased lipid peroxidation in the rat fetal brain after treatment with ethyl docosahexaenoate

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Cytoprotection by neutral fraction of tannat red wine against oxidative stress-induced cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Meal size and frequency affect neuronal plasticity and vulnerability to disease: cellular and molecular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Remarkable increase in the concentration of 8-hydroxyguanosine in cerebrospinal fluid from patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Ribosome dysfunction is an early event in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Evidence of increased oxidative damage in subjects with mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Increase of brain oxidative stress in mild cognitive impairment: a possible predictor of Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Oxidative DNA damage in peripheral leukocytes of mild cognitive impairment and AD patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Oxidative imbalance in patients with mild cognitive impairment and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Glial heme oxygenase-1 expression in Alzheimer disease and mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Oxidative stress precedes fibrillar deposition of Alzheimer's disease amyloid beta-peptide (1-42) in a transgenic Caenorhabditis elegans model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Impaired Cu/Zn-SOD activity contributes to increased oxidative damage in APP transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Oxidative stress induces intracellular accumulation of amyloid beta-protein (Abeta) in human neuroblastoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Effect of the lipid peroxidation product acrolein on tau phosphorylation in neural cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Effects of alpha-tocopherol on an animal model of tauopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Dietary Cu stabilizes brain superoxide dismutase 1 activity and reduces amyloid Abeta production in APP23 transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Increased plaque burden in brains of APP mutant MnSOD heterozygous knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Metabolic, metallic, and mitotic sources of oxidative stress in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Ribosomal RNA in Alzheimer disease is oxidized by bound redox-active iron

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Gene expression profiles of transcripts in amyloid precursor protein transgenic mice: up-regulation of mitochondrial metabolism and apoptotic genes is an early cellular change in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Overexpression of Alzheimer's disease amyloid-beta opposes the age-dependent elevations of brain copper and iron.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Alterations in cerebral blood flow and glucose utilization in mice overexpressing the amyloid precursor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Oligomers on the brain: the emerging role of soluble protein aggregates in neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Alzheimer's disease: a re-examination of the amyloid hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Extracellular neurofibrillary tangles reflect neuronal loss and provide further evidence of extensive protein cross-linking in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Tau suppression in a neurodegenerative mouse model improves memory function

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Amyloid-beta is an antioxidant for lipoproteins in cerebrospinal fluid and plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Human Abeta1-42 reduces iron-induced toxicity in rat cerebral cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Evidence that the beta-amyloid plaques of Alzheimer's disease represent the redox-silencing and entombment of abeta by zinc

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Tau phosphorylation in Alzheimer's disease: pathogen or protector?

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Alzheimer-specific epitopes of tau represent lipid peroxidation-induced conformations

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

In Alzheimer's disease, heme oxygenase is coincident with Alz50, an epitope of tau induced by 4-hydroxy-2-nonenal modification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Antioxidants and prevention of chronic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Antioxidant vitamin intake and risk of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Midlife dietary intake of antioxidants and risk of late-life incident dementia: the Honolulu-Asia Aging Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Vitamin E and donepezil for the treatment of mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Vitamin E and cognitive decline in older persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Antioxidant and prooxidant roles for beta-carotene, alpha-tocopherol and ascorbic acid in human lung cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Oxidative stress, caloric restriction, and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Imatinib mesylate blocks a non-Smad TGF-beta pathway and reduces renal fibrogenesis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Caloric restriction attenuates Abeta-deposition in Alzheimer transgenic models

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Physical activity and risk of cognitive impairment and dementia in elderly persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Leisure activities and the risk of dementia in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Physical activity, APOE genotype, and dementia risk: findings from the Cardiovascular Health Cognition Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Exercise plus behavioral management in patients with Alzheimer disease: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Environmental enrichment reduces Abeta levels and amyloid deposition in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Voluntary exercise decreases amyloid load in a transgenic model of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

In Situ Oxidative Catalysis by Neurofibrillary Tangles and Senile Plaques in Alzheimer’s Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Amyloid-β Deposition in Alzheimer Transgenic Mice Is Associated with Oxidative Stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Nonsteroidal Antiinflammatory Drugs and the Risk of Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

Oxidative stress induces increase in intracellular amyloid beta-protein production and selective activation of betaI and betaII PKCs in NT2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000228136.58062.BF

10.1097/01.JNEN.0000228136.58062.BF

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference